High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients

Bone Marrow Transplantation

Volumn 25, Issue 1, 2000, Pages 67-69

  Avery, R ^a   Pohlman, B ^a   Adal, K ^a   Bolwell, B ^a   Goldman, M ^a   Kalaycio, M ^a   Hall, G ^a   Andresen, S ^a   Mossad, S ^a   Schmitt, S ^a   Mason, P ^a   Longworth, D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Autologous PBPC recipients; C. difficile

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; CLOSTRIDIUM DIFFICILE TOXIN A; METRONIDAZOLE; TOBRAMYCIN; VANCOMYCIN;

ARTICLE; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DIARRHEA; FECES CULTURE; HUMAN; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD STEM CELL; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEM CELL TRANSPLANTATION;

EID: 17444443531     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702086     Document Type: Article

References (20)

1. Bartlett JG. Clostridium difficile: clinical considerations. Rev Infect Dis 1990: 12 (Suppl. 2): S243-S251.
2. McFarland LV, Mulligan ME, Kwok RYY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. New Engl J Med 1989; 320: 204-210.
3. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. New Engl J Med 1994; 330: 257-262.
4. Nath SK, Thornley JH, Kelly M et al. A sustained outbreak of Clostridium difficile in a general hospital: persistence of a toxigenic clone in four units. Infect Control Hosp Epidemiol 1994; 15: 382-389.
5. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am J Gastroenterol 1997; 92: 739-750.
6. Johnson S, Gerding DN. Clostridium difficile-associated diarrhea. Clin Infect Dis 1998; 26: 1027-1036.
7. Grundfest-Broniatowski S, Quader M, Alexander F et al. Clostridium difficile colitis in the critically ill. Dis Colon Rectum 1996; 39: 619-623.
8. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 44 (RR-12), 1995, 1-13.
9. Anglin AM, Klym B, Byers KE et al. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium. Arch Intern Med 1997; 157: 1132-1136.
10. Gerding DN. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clin Infect Dis 1997; 25 (Suppl. 2): S206-S210.
11. Bilgrami S, Feingold JM, Dorsky D et al. Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1999; 23: 1039-1042.
12. Kavan P, Sochor M, Nye O et al. Pseudomembraneous clostridium after autologous bone marrow transplantation. Bone Marrow Transplant 1998; 21: 521-523.
13. Cox GJ, Matsui SM, Lo RS et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology 1994; 107: 1398-1407.
14. Yolken RH, Bishop CA, Townsend TR et al. Infectious gastroenteritis in bone-marrow-transplant recipients. New Engl J Med 1982; 306: 1010-1012.
15. Blakey JL, Barnes GL, Bishop RF, Ekert H. Infectious diarrhea in children undergoing bone-marrow transplantation. Aust NZ J Med 1989; 19: 31-36.
16. Aplin MS, Weiner R, Graham Pole J et al. Enterocolitis in allogeneic marrow transplant patients (abstract). Exp Hematol 1990; 18: 696.
17. Avery R, Pohlman B, Longworth D et al. A randomized prospective trial of single daily dose vancomycin and tobramycin plus oral ciprofloxacin versus standard triple antibiotics in febrile neutropenic recipients of autologous progenitor cell transplants. 15th Annual Meeting, American Society of Transplant Physicians, Chicago, May 1997, Abstr. No. 530.
18. Knapp CC, Sandin RL, Hall GS et al. Comparison of Vidas Clostridium difficile toxin-A assay to cytotoxin-B tissue culture assay for the detection of toxins of C. difficile. Diagn Microbiol Infect Dis 1993; 17: 7-12.
19. Lucas GM, Lechtzin N, Puryear DW et al. Vancomycin-resistant and vancomycin-suspectible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis 1998; 26: 1127-1133.
20. Mossad SB, Longworlh DL, Goormastic M et al. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant 1996; 18: 265-271.